United States· US:0264-7625_7e397c6d-62c4-4aa0-b19d-d01c5ac6d868
POTASSIUM CHLORIDE IN DEXTROSE
A medicinal product containing dextrose; potassium chloride, registered in United States by B. Braun Medical Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXTROSE; POTASSIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11026476250012 CONTAINER in 1 CASE (0264-7625-00) / 1000 mL in 1 CONTAINER
- ndc110264-7625-00
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dextrose; potassium chloride in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIntraven potassium chloride 0.3% (potassium 20mmol/500ml) / glucose 5% infusion 500ml bagsTerumo BCT Ltd
- CzechiaKALIUMCHLORID/GLUCOSE B. BRAUN 0,15% + 5%B. Braun Melsungen AG, Melsungen
- IrelandPotassium Chloride 0.15% w/v & Glucose 5% w/v Solution for InfusionFresenius Kabi Deutschland GmbH
- PolandKalii chloridum 0,15% + Glucosum 5% KabiFresenius Kabi Polska Sp. z o.o.
- Canada(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USPBAXTER CORPORATION
- FinlandKalii Chloridum/Glucosum B.BraunB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Chlorure De Potassium + Glucose Fresenius Kabi, Kaliumchlorid + Glucose Fresenius Kabi
- Czechia · Kaliumchlorid/Glucose B. Braun
- Denmark · Kaliumklorid-Glukose Sad
- Estonia · Potassium Chloride/Glucose Fresenius
- Spain · Glucosa Y Cloruro Potásico Baxter, Potasio En Glucosa Grifols
- France · Chlorure De Potassium Et Glucose Kabi
- United Kingdom (Northern Ireland) · Potassium Chloride & Glucose Fresenius Kabi, Potassium Chloride And Glucose B. Braun Melsungen
- Greece · Potassium Chloride + Dextrose Cooper, Potassium Chloride In Dextrose Βιοσερ
- Ireland · Potassium Chloride & Glucose, Potassium Chloride & Glucose Fresenius Kabi Deutschland
- Italy · Glucosio Con Potassio Cloruro Baxter, Glucosio Con Potassio Cloruro Monico
- Lithuania · Potassium Chloride / Glucose Fresenius
- Luxembourg · Kcl + Glucose, Viaflo Baxter
- Latvia · Potassium Chloride/Glucose Fresenius
- Malta · Potassium Chloride And Glucose Baxter Holding
- Netherlands · Kaliumchloride - Glucose B. Braun
- Poland · Kalii Chloridum + Glucosum Kabi, Potassium Chloride + Glucose B. Braun
- Portugal · Cloreto De Potássio + Glucose Kabi
- Slovakia · Kaliumchlorid/Glucose B. Braun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/63b65a71-cca0-4317-aed6-8267ca27dd94 GET /v1/drugs/63b65a71-cca0-4317-aed6-8267ca27dd94?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "5; .15",
"substance": "DEXTROSE; POTASSIUM CHLORIDE",
"productndc": "0264-7625",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL",
"application_number": "NDA019699",
"marketing_category": "NDA"
}See everything about dextrose; potassium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.